# Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms

> **NCT07638553** · PHASE3 · RECRUITING · sponsor: **Centre Hospitalier Universitaire de Nīmes** · enrollment: 172 (estimated)

## Conditions studied

- Alcohol Use Disorder
- Depressive Sympotoms
- Psilocybin

## Interventions

- **DRUG:** Psilocybin (high dose)
- **DRUG:** Psilocybin (low dose)

## Key facts

- **NCT ID:** NCT07638553
- **Lead sponsor:** Centre Hospitalier Universitaire de Nīmes
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-30
- **Primary completion:** 2030-06
- **Final completion:** 2030-06
- **Target enrollment:** 172 (ESTIMATED)
- **Last updated:** 2026-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07638553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07638553, "Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07638553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*